Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading causes of death in patients who suffer from it. Indeed, ...

Pulmonary hypertension (PAH) is a feared complication of scleroderma and a leading cause of mortality in this disease. In this study, Shah and colleagues evaluated the factors that could predict PAH ...

CLEVELAND — Every patient with systemic sclerosis should be screened for pulmonary arterial hypertension every year, as early recognition, referral and aggressive treatment are necessary to improve ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Pulmonary arterial hypertension’s prevalence and rate of progression in patients with connective ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

More than 40,000 persons die each year in the US from pulmonary fibrosis, but the mortality rate among African-Americans is twice as high Caucasians. A physiologist from Belarus working at the Medical ...

Scleroderma (meaning “hard skin” in Greek) is synonymous with morphea, although the latter term is usually reserved for a benign form of localized disease. All forms of scleroderma are ultimately ...

A drug that is used to treat cancer may be equally effective in treating diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma. A drug that is used to ...